203 related articles for article (PubMed ID: 18768495)
1. Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk.
Roncucci L; Mora E; Mariani F; Bursi S; Pezzi A; Rossi G; Pedroni M; Luppi D; Santoro L; Monni S; Manenti A; Bertani A; Merighi A; Benatti P; Di Gregorio C; de Leon PM
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2291-7. PubMed ID: 18768495
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 and Hypoxia-Inducible Factor-1alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis.
Mariani F; Sena P; Marzona L; Riccio M; Fano R; Manni P; Gregorio CD; Pezzi A; Leon MP; Monni S; Pol AD; Roncucci L
Cancer Lett; 2009 Jul; 279(2):221-9. PubMed ID: 19268443
[TBL] [Abstract][Full Text] [Related]
3. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
4. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
[TBL] [Abstract][Full Text] [Related]
5. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase-positive cell infiltration of normal colorectal mucosa is related to body fatness and is predictive of adenoma occurrence.
Mariani F; Boarino V; Bertani A; Merighi A; Pedroni M; Rossi G; Mancini S; Sena P; Benatti P; Roncucci L
Int J Obes (Lond); 2017 Jun; 41(6):982-985. PubMed ID: 28356561
[TBL] [Abstract][Full Text] [Related]
7. COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics.
McLean MH; Murray GI; Fyfe N; Hold GL; Mowat NA; El-Omar EM
Histopathology; 2008 Jun; 52(7):806-15. PubMed ID: 18462368
[TBL] [Abstract][Full Text] [Related]
8. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolyposis hereditary colorectal cancer, and adenomas.
Love RR; Surawicz TS; Morrissey JF; Verma AK
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):195-8. PubMed ID: 1306105
[TBL] [Abstract][Full Text] [Related]
9. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
Messick CA; Church J; Casey G; Kalady MF
Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
[TBL] [Abstract][Full Text] [Related]
10. Colorectal adenomas produce lysozyme.
Rubio CA
Anticancer Res; 2003; 23(6D):5165-71. PubMed ID: 14981984
[TBL] [Abstract][Full Text] [Related]
11. Hyperplastic polyposis and the risk of colorectal cancer.
Hyman NH; Anderson P; Blasyk H
Dis Colon Rectum; 2004 Dec; 47(12):2101-4. PubMed ID: 15657661
[TBL] [Abstract][Full Text] [Related]
12. Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening.
Hüneburg R; Lammert F; Rabe C; Rahner N; Kahl P; Büttner R; Propping P; Sauerbruch T; Lamberti C
Endoscopy; 2009 Apr; 41(4):316-22. PubMed ID: 19340735
[TBL] [Abstract][Full Text] [Related]
13. Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Grubben MJ; van den Braak CC; Nagengast FM; Peters WH
Eur J Clin Invest; 2006 Mar; 36(3):188-92. PubMed ID: 16506964
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence.
Gimeno-García AZ; Santana-Rodríguez A; Jiménez A; Parra-Blanco A; Nicolás-Pérez D; Paz-Cabrera C; Díaz-González F; Medina C; Díaz-Flores L; Quintero E
Eur J Cancer; 2006 Dec; 42(18):3246-52. PubMed ID: 16973348
[TBL] [Abstract][Full Text] [Related]
15. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the clinicopathologic features between flat and polypoid adenoma.
Kil Lee S; Il Kim T; Kwan Shin S; Ho Kim W; Kim H; Kyu Kim N
Scand J Gastroenterol; 2008; 43(9):1116-21. PubMed ID: 18609172
[TBL] [Abstract][Full Text] [Related]
17. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
20. Aberrant crypt focus size predicts distal polyp histopathology.
Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
